In addition to genetic alterations, PDAC features a dysregulated immune environment with tumorigenic regulatory T cells, intratumoral macrophages producing interleukin 6 (IL-6), and cancer-associated fibroblasts (CAFs) that promote tumor progression [26]. This evidence concerns the gene IL6 and neoplasm.